Cancer

Title
Medication Study for Relapsed Hodgkins Lymphoma
Trial Number
201170101508
Number of Participants
30
Principal Investigator
Eligibility

Research participants must be at least 18 years of age and have biopsy-proven relapsed or refractory lymphoma.Participants may not be pregnant or nursing.

Purpose

This study is for people with relapsed or refractory Hodgkins lymphoma. The purpose is to see what effects (good and bad) a drug called temsirolimus has on you and your lymphoma.

Enrollment

(708) 327-3223

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.